Production (Stage)
Envoy Medical, Inc.
COCH
$1.63
-$0.035-2.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.23% | 22.52% | -51.00% | 37.05% | -28.09% |
| Total Depreciation and Amortization | 27.08% | -2.04% | 16.67% | 23.53% | -29.17% |
| Total Amortization of Deferred Charges | -76.41% | -- | -- | -- | -55.15% |
| Total Other Non-Cash Items | -70.34% | -92.55% | 238.41% | -189.04% | 855.50% |
| Change in Net Operating Assets | 191.29% | -187.22% | 187.34% | 133.53% | 82.04% |
| Cash from Operations | 15.11% | -56.32% | 42.81% | 12.18% | 49.85% |
| Capital Expenditure | -101.12% | 146.15% | -366.53% | -127.52% | -419.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 200.00% | -- | -- |
| Cash from Investing | -101.12% | 186.83% | 22.15% | -624.77% | -419.05% |
| Total Debt Issued | 0.00% | -33.33% | 200.00% | -50.00% | -- |
| Total Debt Repaid | 74.56% | -- | -- | -- | 54.35% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | 1,444.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -97.56% | 66.50% | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -27.68% | -19.46% | 144.04% | -61.10% | 541.95% |
| Foreign Exchange rate Adjustments | 400.00% | -100.00% | 0.00% | 0.00% | 50.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -116.15% | -60.46% | 183.71% | -540.03% | 105.76% |